LI
RPRX icon

LRI Investments’s Royalty Pharma RPRX Stock Holding History

LRI Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Buy
3,135
+239
+8% +$12.4K 0.01% 352
2026
Q1 		$139K Buy
+2,896
New +$127K 0.01% 352

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
TIP
Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LRI Investments's RPRX Position: Q2 2026 in Review

LRI Investments increased its Royalty Pharma (RPRX) stake by 8.3% in Q2 2026, buying an estimated $12.4K and bringing the position to 3,135 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #352.

LRI Investments first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • LRI Investments held 3,135 shares of Royalty Pharma worth $176K as of Q2 2026.
  • LRI Investments bought 239 Royalty Pharma shares in Q2 2026, an estimated $12.4K.
  • Royalty Pharma made up 0.01% of LRI Investments's portfolio in Q2 2026, its #352 holding.
  • LRI Investments first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • 183 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.